Sucralfate Suspension
Product Images NDC 82182-106

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 82182-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pacific Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sucralfate Oral Suspension Contains Sucralfate And Sucralfate Is An α-d-glucopyranoside, β-d- Fructofuranosyl-, Octakis-(hydrogen Sulfate), Aluminum Complex. (Sucralfate Oral Suspension 01)

The given text does not provide enough information to generate a useful description.*

FDA Label Image

Principal Display Panelndc 82182-106-14 20079114sycralfate Oral Suspension1g/10mlone 420ml Bottleshake Well Before Usingavoid Freezingrx Only (Sucralfate Oral Suspension 02)

This is a description for a medication called Sucralfate Oral Suspension. It is available in a 420 mL bottle and contains 1g of Sucralfate per 10mL. The bottle should be shaken well before using and should be stored at controlled room temperature (20-25°C). This medication is intended for oral administration only and each 10mL dose contains 19 Sucralfate. The recommended adult dosage is 1g (2 teaspoons) four times a day on an empty stomach. It is important to read the full prescribing information provided in the package. The medication is manufactured by Pacific Pharma and the expiry date is in June 2023.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.